Inventor · disambiguated record
Leopoldo L. Luistro, Iii
Also filed as: LUISTRO III LEOPOLDO L · LUISTRO III LEOPOLDO LADORES · LUISTRO LEOPOLDO · LUISTRO LEOPOLDO LADORES
5 granted patents·3 pending applications·27 citations·filing 2009–2023
77Inventor score
Top patents by PatentIndex Score
8 records- 0192US10562968B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Feb 18, 2020·18 cites·19 claims
- 0289US11884722B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN BIOTECH INC·Filed 2023·Granted Jan 30, 2024·1 cites·25 claims
- 0386US10844122B2Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereofJANSSEN BIOTECH INC·Filed 2016·Granted Nov 24, 2020·4 cites·8 claims
- 0481US11685777B2Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jun 27, 2023·1 cites·9 claims
- 0578US2024343796A1Anti- gprc5d antibodies, bispecific antigen binding molecules that bind gprc5d and cd3, and uses thereofJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0673US8741889B2Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitorBOYLAN JOHN FREDERICK·Filed 2012·Granted Jun 3, 2014·3 cites·15 claims
- 0757US2022267438A1Trispecific antibody targeting bcma, gprc5d, and cd3JANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0846US2009181944A1Method for cancer therapyBOYLAN JOHN FREDERICK·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Leopoldo L. Luistro, Iii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →